Author

R. Sardar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Biji· 1 shared A. K. Lam· 1 shared A. Singh· 1 shared C. Evans-Molina· 1 shared D. Gupta· 1 shared D. K. Saini· 1 shared D. Satish· 1 shared F. Syed· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Biji

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

β Cell microRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis and as Biomarkers of Diabetes Risk

F. Syed, P. Krishnan, G. Chang, S. R. Langlais, S. Hati, K. Yamada, A. K. Lam, S. Talware, X. Liu, R. Sardar, J. Liu, R. G. Mirmira, C. Evans-Molina

The paper identifies miRNAs in human islets and EVs that change under inflammatory conditions and can serve as biomarkers for type 1 diabetes risk.

bioRxiv · Jun 15, 2023 · PreprintPhysiology

Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples

A. Biji, O. Khatun, S. Swaraj, R. Narayan, R. Rajmani, R. Sardar, D. Satish, S. Mehta, H. Bindhu, M. Jeevan, D. K. Saini, A. Singh, D. Gupta, S. Tripathi

This study identifies prognostic markers and therapeutic targets for COVID-19 by analyzing Omics data from nasal and BALF samples, finding S100 family genes and TXN as key factors, and validating Auranofin as a potential treatment.

bioRxiv · Feb 18, 2021Microbiology